MediPharmSolutions Revenue and Competitors
Estimated Revenue & Valuation
- MediPharmSolutions's estimated annual revenue is currently $6.6M per year.
- MediPharmSolutions's estimated revenue per employee is $144,000
Employee Data
- MediPharmSolutions has 46 Employees.
- MediPharmSolutions grew their employee count by 39% last year.
MediPharmSolutions's People
Name | Title | Email/Phone |
---|
MediPharmSolutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 40 | 5% | N/A | N/A |
#2 | $3.4M | 27 | -21% | N/A | N/A |
#3 | $8.3M | 51 | 2% | N/A | N/A |
#4 | $14.2M | 79 | 0% | N/A | N/A |
#5 | $5.9M | 41 | 5% | N/A | N/A |
#6 | $120.8M | 537 | N/A | N/A | N/A |
#7 | $9.6M | 59 | 4% | N/A | N/A |
#8 | $29.5M | 149 | 2% | N/A | N/A |
#9 | $7.2M | 50 | 6% | N/A | N/A |
#10 | $5.5M | 38 | 12% | N/A | N/A |
What Is MediPharmSolutions?
Medipharm Solutions – We are a team of physicians, dentists, and nursing and pharmacy graduates with decades of biopharmaceutical and clinical research industry experience. When we embarked on this journey of transitioning into the biopharmaceutical and clinical research industry, we faced the tough challenge of acquiring the required knowledge and skills inspite of having the necessary qualifications. Over the years, our careers blossomed as promised, but we have seen the same challenges affecting others similar to us. We brainstormed a solution for those challenges from every aspect of the pharmaceutical and clinical research fields. The result – Medipharm Solutions. It took us more than a year to give Medipharm solutions its present shape. We take pride in what we have contributed so far to our fraternity.
keywords:N/AN/A
Total Funding
46
Number of Employees
$6.6M
Revenue (est)
39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.9M | 46 | 7% | N/A |
#2 | $9.9M | 46 | 2% | N/A |
#3 | N/A | 46 | 7% | N/A |
#4 | $9.2M | 47 | 9% | N/A |
#5 | $12.2M | 47 | 4% | N/A |